$17bn Pfizer-Hospira merger approved on anti-trust conditions
The European Commission has approved Pfizer’s acquisition of Hospira, providing the larger company first divests of its infliximab candidate and several sterile injectables.
Archives for August 4, 2015
Bio-outsourcing set to rise over next 10 years
Biopharma will increase outsourcing of API manufacturing between now and 2025, research shows.